FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095311687> ?p ?o ?g. }

• W2095311687 endingPage "226" @default.
• W2095311687 startingPage "218" @default.
• W2095311687 abstract "Histamine (HDC) inhibits formation and release of phagocyte-derived reactive oxygen species, and thereby protects natural killer (NK) and T cells against oxidative damage. Thus, the addition of histamine may potentially improve the efficacy of interleukin-2 (IL-2). We have explored this potential mechanism clinically in two randomised phase II trials in metastatic renal cell carcinoma (mRCC). In parallel with the clinical trial in Denmark (n=63), we obtained serial blood samples and tumour biopsies searching for a potential histamine effect in situ. At baseline and on-treatment weeks 3 and 8, we monitored the ‘good guys’ (i.e. NK and T cells) and ‘bad guys’ (i.e. monocytes/macrophages and neutrophils) simultaneously in blood (n=59) and tumour tissue (n=44). Patients with high number of monocytes and neutrophils in peripheral blood had very poor survival, with apparently no benefit from either IL-2 alone or IL-2/HDC treatment. Blood monocytes (r=−0.36, P=0.01) and neutrophils (r=−0.46, P=0.001) were negatively correlated with cytotoxicity, whereas blood NK cells were positively correlated with cytotoxicity (r=0.39, P=0.002). Treatment with IL-2 alone resulted in a significantly higher number of circulating monocytes (P=0.037) and intratumoral macrophages (P=0.005) compared with baseline. In contrast, IL-2/HDC resulted in an unchanged number of circulating monocytes and intratumoral macrophages, and in addition, a significantly increased number of intratumoral CD56+ NK cells (P=0.008) and CD8+ T cells (P=0.019) compared with baseline. The study provides evidence that circulating monocytes and neutrophils are powerful negative prognostic factors for IL-2-based immunotherapy and establishes a biological rationale for the potential use of histamine in conjunction with IL-2 in mRCC." @default.
• W2095311687 created "2016-06-24" @default.
• W2095311687 creator A5007280131 @default.
• W2095311687 creator A5011912106 @default.
• W2095311687 creator A5059200225 @default.
• W2095311687 creator A5082539759 @default.
• W2095311687 creator A5084608183 @default.
• W2095311687 date "2006-01-01" @default.
• W2095311687 modified "2023-10-17" @default.
• W2095311687 title "Monocytes and neutrophils as ‘bad guys’ for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma – results from a randomised phase II trial" @default.
• W2095311687 cites W113716995 @default.
• W2095311687 cites W1480357432 @default.
• W2095311687 cites W1524531954 @default.
• W2095311687 cites W1577612079 @default.
• W2095311687 cites W1580207422 @default.
• W2095311687 cites W1775607881 @default.
• W2095311687 cites W1903830321 @default.
• W2095311687 cites W1945598588 @default.
• W2095311687 cites W1965037168 @default.
• W2095311687 cites W1965918790 @default.
• W2095311687 cites W1966497667 @default.
• W2095311687 cites W1967836453 @default.
• W2095311687 cites W1970658466 @default.
• W2095311687 cites W1980875134 @default.
• W2095311687 cites W1981547010 @default.
• W2095311687 cites W1985981664 @default.
• W2095311687 cites W1987171792 @default.
• W2095311687 cites W1994003134 @default.
• W2095311687 cites W2000217512 @default.
• W2095311687 cites W2001680355 @default.
• W2095311687 cites W2018626184 @default.
• W2095311687 cites W2034269086 @default.
• W2095311687 cites W2034486057 @default.
• W2095311687 cites W2037233630 @default.
• W2095311687 cites W2040079124 @default.
• W2095311687 cites W2044175751 @default.
• W2095311687 cites W2045346511 @default.
• W2095311687 cites W2053833244 @default.
• W2095311687 cites W2063413082 @default.
• W2095311687 cites W2073201889 @default.
• W2095311687 cites W2075735730 @default.
• W2095311687 cites W2083261882 @default.
• W2095311687 cites W2109017823 @default.
• W2095311687 cites W2110816260 @default.
• W2095311687 cites W2116554142 @default.
• W2095311687 cites W2127408434 @default.
• W2095311687 cites W2132218438 @default.
• W2095311687 cites W2137822543 @default.
• W2095311687 cites W2140268339 @default.
• W2095311687 cites W2143323652 @default.
• W2095311687 cites W2143813821 @default.
• W2095311687 cites W2144518798 @default.
• W2095311687 cites W2149502530 @default.
• W2095311687 cites W2157485001 @default.
• W2095311687 cites W2161543112 @default.
• W2095311687 cites W2167805334 @default.
• W2095311687 cites W2171469612 @default.
• W2095311687 cites W2334694951 @default.
• W2095311687 cites W4230409530 @default.
• W2095311687 doi "https://doi.org/10.1038/sj.bjc.6602937" @default.
• W2095311687 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2361121" @default.
• W2095311687 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16434984" @default.
• W2095311687 hasPublicationYear "2006" @default.
• W2095311687 type Work @default.
• W2095311687 sameAs 2095311687 @default.
• W2095311687 citedByCount "66" @default.
• W2095311687 countsByYear W20953116872012 @default.
• W2095311687 countsByYear W20953116872013 @default.
• W2095311687 countsByYear W20953116872014 @default.
• W2095311687 countsByYear W20953116872015 @default.
• W2095311687 countsByYear W20953116872016 @default.
• W2095311687 countsByYear W20953116872017 @default.
• W2095311687 countsByYear W20953116872018 @default.
• W2095311687 countsByYear W20953116872019 @default.
• W2095311687 countsByYear W20953116872020 @default.
• W2095311687 countsByYear W20953116872021 @default.
• W2095311687 countsByYear W20953116872022 @default.
• W2095311687 crossrefType "journal-article" @default.
• W2095311687 hasAuthorship W2095311687A5007280131 @default.
• W2095311687 hasAuthorship W2095311687A5011912106 @default.
• W2095311687 hasAuthorship W2095311687A5059200225 @default.
• W2095311687 hasAuthorship W2095311687A5082539759 @default.
• W2095311687 hasAuthorship W2095311687A5084608183 @default.
• W2095311687 hasBestOaLocation W20953116871 @default.
• W2095311687 hasConcept C109316439 @default.
• W2095311687 hasConcept C1122143 @default.
• W2095311687 hasConcept C126322002 @default.
• W2095311687 hasConcept C149532602 @default.
• W2095311687 hasConcept C154317977 @default.
• W2095311687 hasConcept C167672396 @default.
• W2095311687 hasConcept C202751555 @default.
• W2095311687 hasConcept C203014093 @default.
• W2095311687 hasConcept C2777700362 @default.
• W2095311687 hasConcept C2781184567 @default.
• W2095311687 hasConcept C55493867 @default.
• W2095311687 hasConcept C71924100 @default.
• W2095311687 hasConcept C86803240 @default.
• W2095311687 hasConcept C8891405 @default.

• next